Expression of matrix metalloproteinase-12 in aortic dissection
Open Access
- 3 May 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cardiovascular Disorders
- Vol. 13 (1), 34-9
- https://doi.org/10.1186/1471-2261-13-34
Abstract
Background: Aortic dissection(AD) is an acute process of large blood vessels characterized by dangerous pathogenic conditions and high disability and high mortality. The pathogenesis of AD remains debated. Matrix metalloproteinase-12 (MMP-12) participates in many pathological processes such as abdominal aortic aneurysm, atherosclerosis, emphysema and cancer. However, this elastase has rarely been assessed in the presence of AD. The aim of the present study was to investigate the expression of MMP-12 in aortic tissue so as to offer a better understanding of the possible mechanisms of AD. Methods: The protein expression levels of MMP-12 were analyzed and compared in aorta tissue and the blood serum samples by reverse transcription polymerase chain reaction(RT-PCR), Western blotting, immuno-histochemistry, fluorescence resonance energy transfer ( FRET ) activity assay and enzyme-linked immuno sorbent assay ( ELISA ), respectively. Ascending aorta tissue specimens were obtained from 12 patients with an acute Stanford A-dissection at the time of aortic replacement, and from 4 patients with coronary artery disease (CAD) undergoing coronary artery bypass surgery. Meanwhile, serum samples were harvested from 15 patients with an acute Stanford A-dissection and 10 healthy individuals who served as the control group. Results: MMP-12 activity could be detected in both AD and CAD groups, but the level in the AD group was higher than those in the CAD group (P < 0.05). MMP-12 proteolysis existed in both serum samples of the AD and healthy groups, and the activity level in the AD group was clearly higher than in the healthy group (P < 0.05). For AD patients, MMP-12 activity in serum was higher than in the aorta wall (P < 0.05). MMP-12 activity in the aortic wall tissue can be inhibited by MMP inhibitor v (P < 0.05). Conclusion: The present study directly demonstrates that MMP-12 proteolytic activity exists within the aorta specimens and blood samples from aortic dissection patients. MMP-12 might be of potential relevance as a clinically diagnostic tool and therapeutic target in vascular injury and repair.Keywords
This publication has 36 references indexed in Scilit:
- Association of smooth muscle cell phenotypes with extracellular matrix disorders in thoracic aortic dissectionJournal of Vascular Surgery, 2012
- Neutrophil-Derived Matrix Metalloproteinase 9 Triggers Acute Aortic DissectionCirculation, 2012
- Carotid Atherosclerotic Plaque Matrix Metalloproteinase‐12–Positive Macrophage Subpopulation Predicts Adverse Outcome After EndarterectomyJournal of the American Heart Association, 2012
- Acute Aortic Dissection in ChinaThe American Journal of Cardiology, 2012
- The Prominent Expression of Plasma Matrix Metalloproteinase-8 in Acute Thoracic Aortic DissectionJournal of Surgical Research, 2010
- 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic DiseaseCirculation, 2010
- MMP12,Lung Function, and COPD in High-Risk PopulationsThe New England Journal of Medicine, 2009
- Synthetic active site-directed inhibitors of metzincins: Achievement and perspectivesMolecular Aspects of Medicine, 2008
- Up-regulation of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase were coupled with that of type I procollagen in granulation tissue response after the onset of aortic dissectionVirchows Archiv A Pathological Anatomy and Histopathology, 2006
- Decreased Tissue Inhibitor of Metalloproteinase-2/Matrix Metalloproteinase Ratio in the Acute Phase of Aortic DissectionSurgery Today, 2004